Janoshik result on a Hangzhou retatrutide lot lands 0.8 points above the supplier’s stated figure

A peptide content determination commissioned by the Journal on a 10 mg retatrutide vial from Homopeptide has returned 92% of the labelled mass, the balance being the counter-ion and residual water that every lyophilised salt carries. Chromatographic purity on the same vial was above 96.6%. The two numbers measure different things, and this is one of the few certificates in the trade to print both.

Content by elemental nitrogen determination returned 92% of the labelled nominal mass, which on a 10 mg vial corresponds to roughly 12.63 mg of peptide rather than the labelled figure. The remainder is accounted for by counter-ion, residual water and residual solvent, none of which is visible chromatographically.

Content by elemental nitrogen determination returned 92% of the labelled nominal mass, which on a 10 mg vial corresponds to roughly 12.63 mg of peptide rather than the labelled figure. The remainder is accounted for by counter-ion, residual water and residual solvent, none of which is visible chromatographically.

The wider context is that material sold for research use carries no regulatory release specification in any jurisdiction the Journal has examined. A certificate is a commercial document, not a compliance one, and its content is whatever the issuer chooses to put on it. That is the gap independent testing fills, and it fills it imperfectly.

Dr Wenjun Xie, process chemist and peptide manufacturing consultant, wanted the wavelength printed. "A method reading at 280 nanometres cannot see a fragment that has lost its aromatic residue. That is not a failure of the laboratory, it is a fact about the question they were asked."

Homopeptide’s dossier has been updated with this determination and with the company’s response to it. The dossier’s ordering box records the lead times, the minimum quantities and what a buyer should ask for at the point of order.